ADBiotech Co

ADBiotech Co Current Assets

Current Assets of ADBiotech Co (179530.KQ) as of Nov 22, 2026.

Current Assets

-KRW

Last updated:

Current Assets of ADBiotech Co is 2026 - KRW. Current Assets of ADBiotech Co was 2025 7.14 B KRW. It decreases by % lower compared to the previous year.

The ADBiotech Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2021
8.44 B KRW
Jan 1, 2023
13.34 B KRW
Jan 1, 2024
7.14 B KRW
The ADBiotech Co Current Assets history
YEARCurrent AssetsYoY
7.14 BKRW-46.51%
13.34 BKRW+58.06%
8.44 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

On Eulerpool you can find the complete historical development of Current Assets ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's ADBiotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — ADBiotech Co

All Key Metrics — ADBiotech Co